 Kristin Mekeel
Concepts (311)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kidney Transplantation | 24 | 2021 | 603 | 2.990 |
Why?
| | Liver Transplantation | 21 | 2023 | 799 | 2.220 |
Why?
| | Organ Transplantation | 7 | 2024 | 218 | 1.410 |
Why?
| | Liver Diseases | 8 | 2015 | 285 | 1.370 |
Why?
| | Pancreas Transplantation | 7 | 2011 | 74 | 1.290 |
Why?
| | Laparoscopy | 11 | 2016 | 450 | 1.200 |
Why?
| | Nephrectomy | 6 | 2020 | 158 | 1.160 |
Why?
| | Hepatectomy | 8 | 2015 | 209 | 1.140 |
Why?
| | Graft Survival | 10 | 2021 | 503 | 1.120 |
Why?
| | Kidney Failure, Chronic | 7 | 2021 | 540 | 1.070 |
Why?
| | Liver Neoplasms | 7 | 2022 | 633 | 1.060 |
Why?
| | Carcinoma, Hepatocellular | 5 | 2022 | 270 | 1.050 |
Why?
| | Postoperative Complications | 16 | 2024 | 2456 | 1.030 |
Why?
| | Liver Cirrhosis | 4 | 2022 | 279 | 0.980 |
Why?
| | Living Donors | 7 | 2018 | 287 | 0.930 |
Why?
| | Tissue Donors | 8 | 2022 | 388 | 0.920 |
Why?
| | Kidney | 5 | 2021 | 1306 | 0.800 |
Why?
| | Hepatic Stellate Cells | 1 | 2020 | 13 | 0.690 |
Why?
| | Renal Nutcracker Syndrome | 1 | 2020 | 6 | 0.670 |
Why?
| | Pain, Postoperative | 1 | 2022 | 222 | 0.670 |
Why?
| | Bile Ducts, Intrahepatic | 4 | 2013 | 65 | 0.640 |
Why?
| | Students, Medical | 1 | 2023 | 315 | 0.630 |
Why?
| | Waiting Lists | 5 | 2020 | 237 | 0.630 |
Why?
| | Cholangiocarcinoma | 4 | 2013 | 77 | 0.620 |
Why?
| | Bile Duct Neoplasms | 4 | 2013 | 99 | 0.610 |
Why?
| | Cysts | 2 | 2008 | 108 | 0.560 |
Why?
| | Renal Artery | 2 | 2015 | 33 | 0.560 |
Why?
| | Graft Rejection | 7 | 2015 | 557 | 0.540 |
Why?
| | Diabetes Mellitus | 4 | 2021 | 994 | 0.530 |
Why?
| | Blood Vessel Prosthesis Implantation | 3 | 2013 | 198 | 0.530 |
Why?
| | Hepatitis B | 1 | 2016 | 60 | 0.500 |
Why?
| | Tissue and Organ Harvesting | 1 | 2015 | 72 | 0.480 |
Why?
| | Tissue and Organ Procurement | 4 | 2024 | 288 | 0.470 |
Why?
| | Retrospective Studies | 26 | 2024 | 14404 | 0.460 |
Why?
| | Humans | 75 | 2024 | 128019 | 0.460 |
Why?
| | Vascular Diseases | 2 | 2015 | 232 | 0.460 |
Why?
| | Middle Aged | 35 | 2024 | 30812 | 0.450 |
Why?
| | Analgesics, Opioid | 1 | 2022 | 886 | 0.450 |
Why?
| | Salvage Therapy | 1 | 2015 | 133 | 0.440 |
Why?
| | Internship and Residency | 1 | 2023 | 1043 | 0.440 |
Why?
| | Non-alcoholic Fatty Liver Disease | 3 | 2023 | 258 | 0.430 |
Why?
| | Adult | 34 | 2024 | 35176 | 0.430 |
Why?
| | Transplant Recipients | 3 | 2024 | 152 | 0.410 |
Why?
| | Hepatitis C | 4 | 2020 | 234 | 0.390 |
Why?
| | Operating Rooms | 2 | 2024 | 115 | 0.390 |
Why?
| | Pancreatectomy | 2 | 2011 | 241 | 0.380 |
Why?
| | Vena Cava, Inferior | 2 | 2013 | 67 | 0.380 |
Why?
| | Sphincterotomy, Transduodenal | 1 | 2011 | 1 | 0.360 |
Why?
| | Hernia, Ventral | 2 | 2009 | 23 | 0.360 |
Why?
| | Biliary Tract Diseases | 2 | 2012 | 36 | 0.360 |
Why?
| | Treatment Outcome | 24 | 2021 | 10110 | 0.350 |
Why?
| | Ampulla of Vater | 1 | 2011 | 38 | 0.350 |
Why?
| | Female | 40 | 2024 | 68016 | 0.330 |
Why?
| | Spleen | 1 | 2011 | 507 | 0.320 |
Why?
| | Rhabdomyolysis | 1 | 2009 | 22 | 0.320 |
Why?
| | Ascites | 1 | 2009 | 44 | 0.310 |
Why?
| | Pancreas | 1 | 2011 | 304 | 0.310 |
Why?
| | Male | 37 | 2024 | 62757 | 0.310 |
Why?
| | Peritonitis | 1 | 2009 | 81 | 0.300 |
Why?
| | Follow-Up Studies | 13 | 2018 | 4853 | 0.300 |
Why?
| | Echinococcosis, Hepatic | 1 | 2007 | 1 | 0.290 |
Why?
| | Risk Assessment | 2 | 2016 | 3223 | 0.280 |
Why?
| | Gallbladder Neoplasms | 1 | 2007 | 20 | 0.280 |
Why?
| | Aged | 17 | 2024 | 21892 | 0.280 |
Why?
| | Cholecystectomy | 1 | 2007 | 59 | 0.280 |
Why?
| | Bacterial Infections | 1 | 2009 | 232 | 0.270 |
Why?
| | Reoperation | 3 | 2020 | 541 | 0.260 |
Why?
| | Intraoperative Complications | 1 | 2007 | 129 | 0.260 |
Why?
| | Stents | 2 | 2012 | 504 | 0.260 |
Why?
| | Morbidity | 2 | 2023 | 301 | 0.250 |
Why?
| | Mucormycosis | 1 | 2005 | 21 | 0.240 |
Why?
| | Portal Vein | 4 | 2016 | 106 | 0.230 |
Why?
| | Liver Failure | 2 | 2017 | 91 | 0.230 |
Why?
| | Beluga Whale | 1 | 2024 | 1 | 0.230 |
Why?
| | Aortic Aneurysm, Abdominal | 1 | 2005 | 132 | 0.220 |
Why?
| | Pancreatic Neoplasms | 1 | 2011 | 873 | 0.220 |
Why?
| | Incidence | 3 | 2016 | 2614 | 0.220 |
Why?
| | Organ Preservation | 1 | 2024 | 92 | 0.220 |
Why?
| | Perfusion | 1 | 2024 | 188 | 0.210 |
Why?
| | Anemia, Sickle Cell | 1 | 2007 | 253 | 0.210 |
Why?
| | Materia Medica | 1 | 2023 | 1 | 0.210 |
Why?
| | Body Weight | 1 | 2007 | 930 | 0.200 |
Why?
| | Liver Failure, Acute | 1 | 2023 | 63 | 0.200 |
Why?
| | Morphine Derivatives | 1 | 2022 | 16 | 0.200 |
Why?
| | Tablets | 1 | 2022 | 35 | 0.200 |
Why?
| | Surveys and Questionnaires | 2 | 2024 | 5353 | 0.190 |
Why?
| | Chemical and Drug Induced Liver Injury | 1 | 2023 | 131 | 0.180 |
Why?
| | Acute Kidney Injury | 1 | 2009 | 777 | 0.180 |
Why?
| | Time Factors | 9 | 2023 | 6479 | 0.180 |
Why?
| | Glomerular Filtration Rate | 3 | 2015 | 682 | 0.180 |
Why?
| | Length of Stay | 4 | 2015 | 1114 | 0.180 |
Why?
| | Consent Forms | 1 | 2020 | 12 | 0.180 |
Why?
| | Drug Prescriptions | 1 | 2022 | 245 | 0.170 |
Why?
| | Endoscopy, Digestive System | 2 | 2012 | 122 | 0.160 |
Why?
| | Creatinine | 4 | 2015 | 478 | 0.160 |
Why?
| | Pancreaticoduodenectomy | 3 | 2016 | 158 | 0.160 |
Why?
| | Patient Selection | 3 | 2014 | 658 | 0.160 |
Why?
| | Transplantation, Autologous | 1 | 2020 | 211 | 0.160 |
Why?
| | Fellowships and Scholarships | 1 | 2022 | 271 | 0.150 |
Why?
| | Mycophenolic Acid | 2 | 2010 | 89 | 0.150 |
Why?
| | Vaccination | 2 | 2024 | 1343 | 0.150 |
Why?
| | Leadership | 1 | 2022 | 352 | 0.150 |
Why?
| | Antiviral Agents | 3 | 2020 | 710 | 0.140 |
Why?
| | Tomography, X-Ray Computed | 7 | 2016 | 2509 | 0.140 |
Why?
| | Survival Analysis | 4 | 2010 | 1262 | 0.140 |
Why?
| | Viremia | 1 | 2018 | 130 | 0.140 |
Why?
| | Gallbladder Diseases | 2 | 2007 | 9 | 0.140 |
Why?
| | Antibodies, Monoclonal | 5 | 2010 | 1354 | 0.140 |
Why?
| | Cystic Fibrosis | 1 | 2007 | 1048 | 0.140 |
Why?
| | Renal Dialysis | 1 | 2021 | 420 | 0.140 |
Why?
| | Recurrence | 5 | 2018 | 993 | 0.140 |
Why?
| | Granuloma, Plasma Cell | 1 | 2016 | 13 | 0.140 |
Why?
| | Hypertension, Portal | 2 | 2007 | 60 | 0.130 |
Why?
| | Hepacivirus | 1 | 2018 | 235 | 0.130 |
Why?
| | Duodenal Neoplasms | 1 | 2016 | 21 | 0.130 |
Why?
| | Iliac Artery | 2 | 2015 | 54 | 0.130 |
Why?
| | Fatal Outcome | 2 | 2009 | 299 | 0.130 |
Why?
| | Antilymphocyte Serum | 3 | 2010 | 63 | 0.130 |
Why?
| | Hyperglycemia | 2 | 2010 | 326 | 0.130 |
Why?
| | Immunosuppressive Agents | 6 | 2010 | 682 | 0.130 |
Why?
| | Antibodies, Neoplasm | 3 | 2010 | 35 | 0.130 |
Why?
| | Aged, 80 and over | 7 | 2015 | 7029 | 0.130 |
Why?
| | Survival Rate | 3 | 2016 | 1870 | 0.130 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2024 | 1272 | 0.130 |
Why?
| | Prognosis | 3 | 2017 | 3766 | 0.120 |
Why?
| | Registries | 2 | 2021 | 1873 | 0.120 |
Why?
| | Multivariate Analysis | 3 | 2015 | 1492 | 0.120 |
Why?
| | Liver | 2 | 2022 | 1826 | 0.120 |
Why?
| | Glycogen Storage Disease Type II | 1 | 2015 | 7 | 0.120 |
Why?
| | United States | 5 | 2024 | 13785 | 0.120 |
Why?
| | Risk Factors | 7 | 2017 | 9696 | 0.120 |
Why?
| | Family | 2 | 2017 | 648 | 0.120 |
Why?
| | Donor Selection | 1 | 2015 | 75 | 0.120 |
Why?
| | Delayed Graft Function | 2 | 2018 | 30 | 0.120 |
Why?
| | Kidney Function Tests | 1 | 2015 | 145 | 0.110 |
Why?
| | Electronic Health Records | 1 | 2022 | 973 | 0.110 |
Why?
| | California | 1 | 2015 | 398 | 0.110 |
Why?
| | Insulin | 3 | 2010 | 2316 | 0.110 |
Why?
| | Insulin Resistance | 1 | 2022 | 1164 | 0.110 |
Why?
| | Quality Improvement | 1 | 2022 | 1093 | 0.110 |
Why?
| | Child | 7 | 2020 | 20636 | 0.110 |
Why?
| | Regression Analysis | 2 | 2014 | 978 | 0.110 |
Why?
| | Global Health | 1 | 2016 | 327 | 0.110 |
Why?
| | Practice Patterns, Physicians' | 1 | 2022 | 1260 | 0.110 |
Why?
| | Geography | 1 | 2014 | 186 | 0.100 |
Why?
| | Pregnancy Trimester, Second | 1 | 2013 | 77 | 0.100 |
Why?
| | Young Adult | 7 | 2023 | 12281 | 0.100 |
Why?
| | Pancreatic Ducts | 2 | 2011 | 79 | 0.100 |
Why?
| | Surgical Wound Infection | 4 | 2009 | 281 | 0.100 |
Why?
| | End Stage Liver Disease | 1 | 2014 | 77 | 0.100 |
Why?
| | Heart Transplantation | 1 | 2018 | 711 | 0.100 |
Why?
| | Hepatocytes | 2 | 2023 | 213 | 0.090 |
Why?
| | Contraindications | 1 | 2011 | 87 | 0.090 |
Why?
| | Splenectomy | 1 | 2011 | 57 | 0.090 |
Why?
| | Aspartate Aminotransferases | 2 | 2012 | 86 | 0.090 |
Why?
| | Bilirubin | 2 | 2012 | 92 | 0.090 |
Why?
| | Hospital Mortality | 1 | 2015 | 844 | 0.090 |
Why?
| | Surgical Mesh | 2 | 2009 | 46 | 0.090 |
Why?
| | Hypoglycemic Agents | 2 | 2010 | 1212 | 0.090 |
Why?
| | Acetaminophen | 1 | 2013 | 245 | 0.090 |
Why?
| | Disease Models, Animal | 1 | 2020 | 3936 | 0.080 |
Why?
| | Cholestasis | 2 | 2012 | 228 | 0.080 |
Why?
| | Constriction, Pathologic | 1 | 2011 | 228 | 0.080 |
Why?
| | C-Peptide | 1 | 2010 | 163 | 0.080 |
Why?
| | Atrophy | 1 | 2010 | 170 | 0.080 |
Why?
| | Sclerosis | 1 | 2009 | 12 | 0.080 |
Why?
| | Hemobilia | 1 | 2009 | 1 | 0.080 |
Why?
| | Paracentesis | 1 | 2009 | 12 | 0.080 |
Why?
| | Physical Endurance | 1 | 2010 | 262 | 0.080 |
Why?
| | Interferon-alpha | 1 | 2010 | 192 | 0.080 |
Why?
| | Kidney Tubules | 1 | 2010 | 114 | 0.080 |
Why?
| | Inpatients | 2 | 2010 | 464 | 0.080 |
Why?
| | Plasmapheresis | 1 | 2009 | 22 | 0.080 |
Why?
| | Polycystic Kidney, Autosomal Dominant | 1 | 2012 | 223 | 0.080 |
Why?
| | Drug Overdose | 1 | 2013 | 319 | 0.080 |
Why?
| | Boronic Acids | 1 | 2009 | 37 | 0.080 |
Why?
| | Intestinal Obstruction | 1 | 2009 | 49 | 0.080 |
Why?
| | Surgical Stapling | 1 | 2008 | 13 | 0.080 |
Why?
| | Hepatomegaly | 1 | 2008 | 5 | 0.080 |
Why?
| | Isoantibodies | 1 | 2009 | 48 | 0.080 |
Why?
| | Protease Inhibitors | 1 | 2009 | 104 | 0.070 |
Why?
| | Adolescent | 5 | 2016 | 20158 | 0.070 |
Why?
| | Pyrazines | 1 | 2009 | 86 | 0.070 |
Why?
| | Malnutrition | 1 | 2009 | 79 | 0.070 |
Why?
| | Pancreatitis | 1 | 2009 | 128 | 0.070 |
Why?
| | Cadaver | 1 | 2009 | 306 | 0.070 |
Why?
| | Liver Function Tests | 1 | 2008 | 107 | 0.070 |
Why?
| | Abdominal Pain | 1 | 2009 | 144 | 0.070 |
Why?
| | Pancreatic Diseases | 1 | 2008 | 67 | 0.070 |
Why?
| | HLA Antigens | 1 | 2009 | 234 | 0.070 |
Why?
| | Societies, Medical | 2 | 2024 | 741 | 0.070 |
Why?
| | Fibrosis | 1 | 2010 | 513 | 0.070 |
Why?
| | Liver Cirrhosis, Biliary | 1 | 2007 | 18 | 0.070 |
Why?
| | Incidental Findings | 1 | 2007 | 79 | 0.070 |
Why?
| | Decompression, Surgical | 1 | 2007 | 99 | 0.070 |
Why?
| | Diabetic Nephropathies | 1 | 2010 | 278 | 0.070 |
Why?
| | Prednisone | 1 | 2007 | 230 | 0.070 |
Why?
| | Tacrolimus | 1 | 2007 | 140 | 0.070 |
Why?
| | Sirolimus | 1 | 2007 | 189 | 0.070 |
Why?
| | Lymph Node Excision | 1 | 2007 | 164 | 0.070 |
Why?
| | Iris Neoplasms | 1 | 2006 | 1 | 0.060 |
Why?
| | Focal Nodular Hyperplasia | 1 | 2006 | 3 | 0.060 |
Why?
| | Diagnostic Techniques, Digestive System | 1 | 2006 | 12 | 0.060 |
Why?
| | Aneurysm, False | 1 | 2006 | 48 | 0.060 |
Why?
| | Treatment Failure | 1 | 2007 | 338 | 0.060 |
Why?
| | Anastomosis, Surgical | 1 | 2006 | 149 | 0.060 |
Why?
| | Walking | 1 | 2010 | 494 | 0.060 |
Why?
| | Weight Gain | 1 | 2009 | 503 | 0.060 |
Why?
| | Severity of Illness Index | 1 | 2014 | 2703 | 0.060 |
Why?
| | Lymphoproliferative Disorders | 1 | 2006 | 54 | 0.060 |
Why?
| | Alemtuzumab | 3 | 2010 | 15 | 0.060 |
Why?
| | Polyethylene Glycols | 1 | 2010 | 598 | 0.060 |
Why?
| | Magnetic Resonance Imaging | 1 | 2017 | 3371 | 0.060 |
Why?
| | Digestive System Surgical Procedures | 1 | 2006 | 96 | 0.060 |
Why?
| | Biopsy | 3 | 2016 | 1077 | 0.060 |
Why?
| | Adenoma | 1 | 2006 | 212 | 0.050 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2010 | 2428 | 0.050 |
Why?
| | Neoplasm Staging | 1 | 2007 | 1288 | 0.050 |
Why?
| | Mice | 1 | 2020 | 16574 | 0.050 |
Why?
| | Shock, Septic | 1 | 2005 | 207 | 0.050 |
Why?
| | Terminology as Topic | 1 | 2024 | 199 | 0.050 |
Why?
| | Animals | 2 | 2024 | 34487 | 0.050 |
Why?
| | Informatics | 1 | 2022 | 7 | 0.050 |
Why?
| | Cell Separation | 1 | 2023 | 312 | 0.050 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2009 | 2059 | 0.050 |
Why?
| | Prospective Studies | 3 | 2022 | 7035 | 0.050 |
Why?
| | Academic Medical Centers | 1 | 2024 | 478 | 0.050 |
Why?
| | Necrosis | 1 | 2022 | 228 | 0.040 |
Why?
| | Quality of Life | 2 | 2010 | 2672 | 0.040 |
Why?
| | Mortality | 1 | 2022 | 306 | 0.040 |
Why?
| | Antibodies, Monoclonal, Humanized | 3 | 2010 | 754 | 0.040 |
Why?
| | Observer Variation | 1 | 2020 | 310 | 0.040 |
Why?
| | Patient Outcome Assessment | 1 | 2020 | 125 | 0.040 |
Why?
| | Inflammation | 1 | 2010 | 2646 | 0.040 |
Why?
| | Antibodies, Monoclonal, Murine-Derived | 2 | 2009 | 87 | 0.040 |
Why?
| | Dietary Supplements | 1 | 2023 | 531 | 0.040 |
Why?
| | Renal Replacement Therapy | 1 | 2018 | 87 | 0.040 |
Why?
| | Communication | 1 | 2024 | 838 | 0.040 |
Why?
| | Allografts | 1 | 2018 | 136 | 0.040 |
Why?
| | Rituximab | 2 | 2009 | 162 | 0.040 |
Why?
| | Immunoglobulins, Intravenous | 2 | 2009 | 130 | 0.040 |
Why?
| | Cholangiography | 1 | 2016 | 17 | 0.030 |
Why?
| | Child, Preschool | 2 | 2013 | 10378 | 0.030 |
Why?
| | International Cooperation | 1 | 2017 | 171 | 0.030 |
Why?
| | Abdominal Neoplasms | 1 | 2016 | 34 | 0.030 |
Why?
| | Feasibility Studies | 1 | 2020 | 860 | 0.030 |
Why?
| | Viral Load | 1 | 2018 | 449 | 0.030 |
Why?
| | Drug Therapy, Combination | 2 | 2010 | 1012 | 0.030 |
Why?
| | Adrenal Cortex Hormones | 2 | 2010 | 518 | 0.030 |
Why?
| | Cells, Cultured | 1 | 2023 | 4006 | 0.030 |
Why?
| | Matched-Pair Analysis | 1 | 2015 | 40 | 0.030 |
Why?
| | Curriculum | 1 | 2022 | 909 | 0.030 |
Why?
| | alpha-Glucosidases | 1 | 2015 | 12 | 0.030 |
Why?
| | Heart | 1 | 2018 | 637 | 0.030 |
Why?
| | ROC Curve | 1 | 2015 | 500 | 0.030 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2010 | 3625 | 0.030 |
Why?
| | Infant | 1 | 2007 | 8912 | 0.030 |
Why?
| | Gastrointestinal Stromal Tumors | 1 | 2013 | 46 | 0.030 |
Why?
| | Hepatoblastoma | 1 | 2013 | 41 | 0.020 |
Why?
| | Diagnosis, Differential | 1 | 2016 | 1408 | 0.020 |
Why?
| | Alkaline Phosphatase | 1 | 2012 | 142 | 0.020 |
Why?
| | Alanine Transaminase | 1 | 2012 | 151 | 0.020 |
Why?
| | Biomarkers | 2 | 2015 | 3874 | 0.020 |
Why?
| | Neoplasm Invasiveness | 1 | 2013 | 477 | 0.020 |
Why?
| | Cholangiopancreatography, Endoscopic Retrograde | 1 | 2012 | 206 | 0.020 |
Why?
| | Arizona | 1 | 2010 | 78 | 0.020 |
Why?
| | Cohort Studies | 2 | 2011 | 5378 | 0.020 |
Why?
| | Ribavirin | 1 | 2010 | 91 | 0.020 |
Why?
| | Blood Glucose | 2 | 2010 | 2092 | 0.020 |
Why?
| | Medical History Taking | 1 | 2009 | 116 | 0.020 |
Why?
| | Cholangiopancreatography, Magnetic Resonance | 1 | 2009 | 17 | 0.020 |
Why?
| | Obesity | 1 | 2022 | 2859 | 0.020 |
Why?
| | Ileus | 1 | 2009 | 12 | 0.020 |
Why?
| | Chi-Square Distribution | 1 | 2010 | 511 | 0.020 |
Why?
| | Bortezomib | 1 | 2009 | 45 | 0.020 |
Why?
| | Bile Ducts | 1 | 2009 | 67 | 0.020 |
Why?
| | Histocompatibility Testing | 1 | 2009 | 120 | 0.020 |
Why?
| | Hematologic Diseases | 1 | 2009 | 60 | 0.020 |
Why?
| | Diabetic Retinopathy | 1 | 2010 | 172 | 0.020 |
Why?
| | Kaplan-Meier Estimate | 1 | 2010 | 851 | 0.020 |
Why?
| | Prosthesis-Related Infections | 1 | 2009 | 73 | 0.020 |
Why?
| | Poisoning | 1 | 2009 | 111 | 0.020 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2013 | 620 | 0.020 |
Why?
| | Recombinant Fusion Proteins | 1 | 2010 | 634 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2010 | 1020 | 0.020 |
Why?
| | Acute Disease | 1 | 2010 | 961 | 0.020 |
Why?
| | Diabetes Complications | 1 | 2009 | 223 | 0.020 |
Why?
| | Respiratory Tract Diseases | 1 | 2009 | 148 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 2010 | 1286 | 0.020 |
Why?
| | Radiotherapy, Conformal | 1 | 2007 | 70 | 0.020 |
Why?
| | RNA, Viral | 1 | 2010 | 615 | 0.020 |
Why?
| | Hepatic Artery | 1 | 2006 | 58 | 0.020 |
Why?
| | Microsurgery | 1 | 2006 | 70 | 0.020 |
Why?
| | Angiography | 1 | 2006 | 192 | 0.020 |
Why?
| | Colorectal Neoplasms | 1 | 2013 | 746 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2010 | 1934 | 0.020 |
Why?
| | Logistic Models | 1 | 2010 | 1975 | 0.010 |
Why?
| | Herpesvirus 4, Human | 1 | 2006 | 152 | 0.010 |
Why?
| | Pilot Projects | 1 | 2009 | 1559 | 0.010 |
Why?
| | Genotype | 1 | 2009 | 1828 | 0.010 |
Why?
| | Safety | 1 | 2006 | 328 | 0.010 |
Why?
| | Cause of Death | 1 | 2006 | 392 | 0.010 |
Why?
| | Catheter Ablation | 1 | 2007 | 333 | 0.010 |
Why?
| | Age Factors | 1 | 2009 | 3100 | 0.010 |
Why?
| | Prevalence | 1 | 2009 | 2541 | 0.010 |
Why?
| | Antibodies, Viral | 1 | 2006 | 601 | 0.010 |
Why?
| | Body Mass Index | 1 | 2009 | 2260 | 0.010 |
Why?
| | Pregnancy | 1 | 2013 | 6355 | 0.010 |
Why?
| | Practice Guidelines as Topic | 1 | 2007 | 1482 | 0.010 |
Why?
| | Cardiovascular Diseases | 1 | 2010 | 1994 | 0.010 |
Why?
| | Antineoplastic Agents | 1 | 2007 | 2041 | 0.010 |
Why?
|
|
Mekeel's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|